Connor, Clark & Lunn Investment Management Ltd. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$845,305
-73.6%
76,360
-61.3%
0.00%
-75.0%
Q2 2023$3,200,032
+112.5%
197,411
+118.3%
0.02%
+100.0%
Q1 2023$1,505,593
+81.5%
90,426
+2.5%
0.01%
+60.0%
Q4 2022$829,512
+17.3%
88,246
-66.0%
0.01%0.0%
Q3 2022$707,000
+9.8%
259,887
+16.6%
0.01%
+25.0%
Q2 2022$644,000
+80.9%
222,862
+87.7%
0.00%
+100.0%
Q1 2022$356,000
+97.8%
118,706
+202.8%
0.00%
+100.0%
Q4 2021$180,000
+20.0%
39,199
+63.7%
0.00%0.0%
Q3 2021$150,000
+78.6%
23,950
+70.9%
0.00%
Q2 2021$84,00014,0110.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 250,000$2,005,0005.90%
Sio Capital Management, LLC 731,453$5,866,0001.40%
KNOTT DAVID M 218,102$1,749,0000.71%
ArrowMark Colorado Holdings LLC 8,813,578$70,685,0000.63%
DAFNA Capital Management LLC 209,200$1,678,0000.58%
Park West Asset Management LLC 1,545,075$12,391,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 590,000$4,732,0000.39%
Cornerstone Capital, Inc. 245,796$1,971,0000.28%
Ikarian Capital, LLC 150,000$1,203,0000.20%
Ikarian Capital, LLC 150,000$1,203,0000.20%
View complete list of VIKING THERAPEUTICS INC shareholders